As I expected… Q3 lack luster
QAP sales up, VTM non existent. Q3 boosted by Kinlytic partial revenue recognition ($1.3m)
Hard pill is write offs of VTM inventory that has a shelf life.
Sales to other provinces not there apparently? What of ON's own expiring stocks and need for replenishment ?
I'm Optimistic for fiscal 2024 that begins in 8 weeks so will continue to acquire on weakness.
MM